Siegfried Holding AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGFEF research report →
Companywww.siegfried.ch
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production.
- CEO
- Marcel Imwinkelried
- IPO
- 2014
- Employees
- 3,886
- HQ
- Zofingen, CH
Price Chart
Valuation
- Market Cap
- $4.38B
- P/E
- 21.00
- P/S
- 2.67
- P/B
- 3.14
- EV/EBITDA
- 13.25
- Div Yield
- 0.49%
Profitability
- Gross Margin
- 26.66%
- Op Margin
- 15.74%
- Net Margin
- 12.70%
- ROE
- 15.68%
- ROIC
- 9.22%
Growth & Income
- Revenue
- $1.33B · 2.62%
- Net Income
- $168.74M · 5.42%
- EPS
- $3.85 · 3.77%
- Op Income
- $210.43M
- FCF YoY
- 182.67%
Performance & Tape
- 52W High
- $1001.00
- 52W Low
- $100.00
- 50D MA
- $100.00
- 200D MA
- $105.21
- Beta
- 0.77
- Avg Volume
- 58.16
Get TickerSpark's AI analysis on SGFEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SGFEF Coverage
We haven't published any research on SGFEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SGFEF Report →